HomeMARKSANS • NSE
add
Marksans Pharma Ltd
Previous close
₹204.69
Day range
₹194.10 - ₹208.24
Year range
₹130.00 - ₹358.70
Market cap
91.29B INR
Avg Volume
1.15M
P/E ratio
24.51
Dividend yield
0.30%
Primary exchange
NSE
Market news
Yahoo Finance
6 hours ago
Stock market today: Dow, S&P 500, Nasdaq rise as Trump tariffs stalk markets
8.69%
1.76%
1.48%
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 6.82B | 16.33% |
Operating expense | 2.65B | 31.21% |
Net income | 1.05B | 25.62% |
Net profit margin | 15.34 | 8.03% |
Earnings per share | — | — |
EBITDA | 1.30B | 9.45% |
Effective tax rate | 26.66% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.72B | 1.65% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 23.05B | — |
Shares outstanding | 452.65M | — |
Price to book | 4.07 | — |
Return on assets | — | — |
Return on capital | 11.79% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.05B | 25.62% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1992
Website
Employees
1,141
